Targeting BCL2 With Venetoclax Is a Promising Therapeutic Strategy for "Double-Protein-Expression" Lymphoma With MYC and BCL2 Rearrangements
Haematologica - Italy
doi 10.3324/haematol.2018.204958
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 6, 2018
Authors
Publisher
Ferrata Storti Foundation (Haematologica)